<bill session="118" type="h" number="1827" updated="2024-07-24T15:23:10Z">
  <state datetime="2023-03-28">REFERRED</state>
  <status>
    <introduced datetime="2023-03-28"/>
  </status>
  <introduced datetime="2023-03-28"/>
  <titles>
    <title type="display">Pausing Enhanced Pandemic Pathogen Research Act of 2023</title>
    <title type="short" as="introduced">Pausing Enhanced Pandemic Pathogen Research Act of 2023</title>
    <title type="official" as="introduced">To prohibit the National Institutes of Health from conducting or supporting certain gain-of-function research, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C001103"/>
  <cosponsors>
    <cosponsor bioguide_id="B001317" joined="2023-04-25"/>
    <cosponsor bioguide_id="C001063" joined="2023-03-28"/>
    <cosponsor bioguide_id="G000579" joined="2023-03-28"/>
    <cosponsor bioguide_id="L000589" joined="2023-05-11"/>
    <cosponsor bioguide_id="R000610" joined="2023-04-26"/>
  </cosponsors>
  <actions>
    <action datetime="2023-03-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-03-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2023-04-07">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Medical research"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2023-10-12T16:31:38Z" status="Introduced in House">Pausing Enhanced Pandemic Pathogen Research Act of 2023

This bill generally prohibits the National Institutes of Health from conducting or supporting gain-of-function research through March 30, 2028. The bill defines gain-of-function research as any research that could enhance the transmissibility, virulence, or pathogenicity of any pathogen or non-pathogen agent in a way that could lead to (1) moderate or high transmissibility, virulence, or pathogenicity in human populations; (2) significant morbidity or mortality in humans; or (3) severe threats to public health or U.S. national security.

The prohibition does not apply to the characterization or testing of naturally occurring influenza virus or coronavirus unless the characterization or testing could increase viral pathogenicity or transmissibility.</summary>
</bill>
